Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-22-049213

Chief Executive Officer acquired 3,125 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Harris Todd Chief Executive Officer 2022-03-15 Grant or award +3,125 $8.53 $26,642 1,699,468 D
Derivatives
Harris Todd Chief Executive Officer 2022-09-06 Grant or award · Stock Option (Right to Buy) +270,000 270,000 D
Loading xslF345X03/doc4.xml…